Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Arch Venture Corp > Profile

Instuitional Investor - Arch Venture Corp

Fund Profile
Filing Period:
Fund Name: Arch Venture Corp
Portfolio Value $230,217,188
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Beam Therapeutics Inc.
 BEAM 4,540,132 $112,595,274 48.9%
2.
Rapport Therapeutics Inc.
 3,728,738 $66,147,812 28.73%
3.
Erasca Inc.
 ERAS 11,055,554 $27,749,441 12.05%
4.
Verve Therapeutics Inc.
 VERV 2,008,809 $11,329,683 4.92%
5.
Gossamer Bio Inc.
 GOSS 8,055,916 $7,287,382 3.16%
Insider Monkey Quarterly Strategy
+334.6% Insider Monkey Quarterly Strategy
+149.4% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)